eIF5A (eukaryotic translation initiation factor 5A) is the only cellular protein containing hypusine [N ε -(4-amino-2-hydroxybutyl)lysine]. eIF5A is activated by the post-translational synthesis of hypusine and the hypusine modification is essential for cell proliferation. In the present study, we report selective acetylation of the hypusine and/or deoxyhypusine residue of eIF5A by a key polyamine catabolic enzyme SSAT1 (spermidine/spermine-N 1 -acetyltransferase 1). This enzyme normally catalyses the N 1 -acetylation of spermine and spermidine to form acetyl-derivatives, which in turn are degraded to lower polyamines. Although SSAT1 has been reported to exert other effects in cells by its interaction with other cellular proteins, eIF5A is the first target protein specifically acetylated by SSAT1. Hypusine or deoxyhypusine, as the free amino acid, does not act as a substrate for SSAT1, suggesting a macromolecular interaction between eIF5A and SSAT1. Indeed, the binding of eIF5A and SSAT1 was confirmed by pull-down assays. The effect of the acetylation of hypusine on eIF5A activity was assessed by comparison of acetylated with non-acetylated bovine testis eIF5A in the methionyl-puromycin synthesis assay. The loss of eIF5A activity by this SSAT1-mediated acetylation confirms the strict structural requirement for the hypusine side chain and suggests a possible regulation of eIF5A by hypusine acetylation/deacetylation.
INTRODUCTION
SSAT1 (spermidine/spermine-N 1 -acetyltransferase 1) is the key enzyme in the metabolism of polyamines and catalyses acetylation of spermidine or spermine at the N 1 of the aminopropyl moiety (reviewed in [1, 2] ). The monoacetylated spermidine or spermine is oxidatively degraded by N 1 -acetylpolyamine oxidase to Nacetylaminopropanal and a smaller polyamine, or the acetylated polyamines may be excreted from cells leading to a decrease in cellular polyamine levels. The level of SSAT1 is normally very low, but can be rapidly induced by a variety of stimuli, including polyamines, polyamine analogues, toxic chemicals, certain drugs and growth factors. Induction of SSAT1 results in an increase in metabolic flux, calorie consumption and fatty acid metabolism [3−6] and SSAT1 has been implicated in pathological conditions such as pancreatitis [7] , obesity and diabetes [3, 5, 6] . SSAT1 has also been implicated in cancer, for its growth suppressive effects through depletion of polyamines, and also for its transforming effects due to increased tissue putrescine or due to reactive oxygen species generated from oxidation of acetyl polyamines [8, 9] .
In addition to its role in polyamine catabolism, SSAT1 has been proposed to interact with certain cellular proteins. It has been reported to be involved in integrin-mediated cell migration via its binding to the α9β1 integrin [10] , which functions in conjunction with the potassium channel Kir4.2, which is modulated by local polyamine concentrations [11] . SSAT1 and the closely related enzyme SSAT2 (also termed TLAT, thialysine acetyltransferase) were implicated in the regulation of HIF-1α (hypoxia-inducible factor-1α) via their binding to it [12, 13] . The binding of SSAT1 to the diamine exporter protein SLC3A2 suggests a concerted mechanism of polyamine acetylation and its export. Although these effects appear to be dependent on SSAT1 enzyme activity, it is unclear whether they are mediated by acetylation of polyamines or by acetylation of these SSAT1 binding partners or other substrates. The auto-acetylation of a specific lysine residue (Lys 26 ) and the open active site structure of SSAT1 [14] leave open the possible acetylation of other substrates beside polyamines.
The putative eIF5A (eukaryotic translation initiation factor 5A; see the Experimental section for notes on nomenclature) contains a polyamine−lysine conjugated amino acid, hypusine [N ε -(4-amino-2-hydroxybutyl)lysine] (at one site, 1 mol per mol) (see reviews [15−17] ), which is essential for its activity. The long side chain of the hypusine/deoxyhypusine resembles the polyamine spermidine/homospermidine. Hypusine is formed post-translationally in the eIF5A precursor, eIF5A(Lys), by two consecutive enzymatic steps. In the first step, DHS (deoxyhypusine synthase) catalyses the transfer of the aminobutyl moiety from the polyamine spermidine to a specific lysine residue (Lys 50 for the human eIF5A) to form the deoxyhypusine [N ε -(4-aminobutyl)lysine] intermediate [18] . This deoxyhypusine residue is subsequently hydroxylated by DOHH (deoxyhypusine hydroxylase) [19] to form the biologically active eIF5A. The vital role of the hypusine/deoxyhypusine modification and eIF5A in eukaryotic and mammalian cell proliferation has been established from gene disruption studies of eIF5A and DHS in the yeast Saccharomyces cerevisiae and from studies involving the inhibition of polyamine or hypusine biosynthesis [20−25] .
Although eIF5A is essential for eukaryotic cell growth and survival, the precise cellular function of this putative initiation factor is not fully understood. eIF5A stimulates methionylpuromycin synthesis, a model assay for the first peptide bond formation, in a hypusine-dependent manner [26, 27] . Recent evidence for the association of eIF5A with actively translating ribosomes [28, 29] and the increase in the polysome/monosome ratio in certain eIF5A mutant yeast strains suggest a role for eIF5A in the elongation step of translation [30, 31] .
eIF5A is an abundant protein with a long half-life ( 24h) and the hypusine modification is an irreversible process. Thus it is difficult to manipulate the cellular level of eIF5A by the use of inhibitors in the pathways of polyamine biosynthesis or hypusine modification. Therefore we explored other potential mechanisms of regulation for eIF5A activity. Lys 47 and Lys 68 of eIF5A have been reported as targets for acetylation [32, 33] . Comparison of the three different human eIF5A mutants involving Lys 47 , K47A, K47D and K47R, provided an interesting insight into the role of Lys 47 [4] . The fact that eIF5A activity was partially impaired by alanine substitution for Lys 47 and totally by aspartate substitution, but not by arginine substitution, suggests that the basic charge of Lys 47 is important for its activity and that eIF5A activity is negatively regulated by acetylation in cells.
In searching for the cellular acetyltransferase that is involved in eIF5A acetylation, we tested four HAT (histone acetyltransferase) recombinant enzymes; p300, CBP [CREB (cAMP-responseelement-binding protein)-binding protein], PCAF (p300/CBPassociated factor) and GCN5 (general control non-derepressible 5), and also the polyamine acetyltransferase SSAT1 and its sequence-related enzyme SSAT2 (TLAT) [34] in vitro. We observed acetylation of the non-hypusinated eIF5A precursor eIF5A(Lys) by p300 and CBP. Interestingly, unlike eIF5A(Lys), the hypusine-containing eIF5A was effectively acetylated by SSAT1, but not by any of the other enzymes tested, and the site of acetylation was determined to be the N-terminal group of the hypusine side chain. Acetylation of the hypusine residue by SSAT1 inactivates eIF5A activity in a methionyl-puromycin synthesis assay in vitro and suggests a potential regulation of eIF5A activity by reversible acetylation/deacetylation at this site.
EXPERIMENTAL

Nomenclature
The term eIF5A usually refers to the native, naturally occurring eukaryotic protein that contains hypusine. Where it is necessary to indicate the specific form, e.g. for recombinant proteins produced in E. coli, the terms, eIF5A(Lys), eIF5A(Dhp) (eIF5A intermediate containing deoxyhypusine) or eIF5A(Hpu) (eIF5A containing hypusine) are used. In certain contexts, eIF5A may also refer to the eIF5A polypeptide irrespective of its modification status. , precast Tris/glycine and NuPAGE (Bis-Tris) gels, and electrophoresis buffers were from Invitrogen, and the ECL (enhanced chemiluminescence) Plus western blotting detection system was from GE Healthcare. A monoclonal antibody against recombinant human eIF5A (amino acids 58−154) was purchased from BD Biosciences, anti-AcLys (acetyl-lysine) antibody was from Santa Cruz Biotechnology. The anti-FLAG antibody (mouse monoclonal) and polyamines, putrescine, spermidine and spermine were from Sigma. Deoxyhypusine and hypusine were chemically synthesized as described previously [35] . Recombinant SSAT1 and SSAT2 enzymes were purified as described previously [34] . Radiolabelled eIF5A([ 3 H]Dhp) was produced in an in vitro DHS reaction [36] . Recombinant eIF5A proteins produced in Escherichia coli, eIF5A(Lys), eIF5A(Dhp) and eIF5A(Hpu), were purified from E. coli cells using a polycistronic vector pST39 encoding human eIF5A-1 alone, two proteins (human eIF5A-1 and DHS) and all three proteins (human eIF5A-1, DHS and DOHH) respectively [36a] . These recombinant eIF5A proteins were used for the majority of experiments in Figures 1−4 . Mammalian eIF5A (hypusine form) was purified from human red blood cells [37] , Chinese hamster ovary cells [27] and rabbit reticulocyte lysates [38] • C. After washing with TBST buffer three times, blotted membranes were incubated with the anti-mouse secondary antibodies for 1 h at room temperature (25 • C) and were visualized by chemiluminescence. For immunoprecipitation, cell lysate containing 2 mg of total protein was pre-incubated with Protein A/G beads for 30 min to remove non-specific binding proteins. The lysate was then incubated with anti-FLAG or anti-eIF5A1 antibody and Protein A/G beads overnight. After washing the precipitates three times, the precipitates were dissolved in SDS sample buffer for SDS/PAGE and Western blotting.
Materials
In vitro HAT, SSAT1 and SSAT2 acetyltransferase reactions
A typical reaction mixture in 50 μl contained in Buffer H (50 mM Tris/HCl, pH 8.0, 1 mM DTT (dithiothreitol), 10 % (v/v) glycerol, 0.1 mM EDTA) [ 3 H]AcCoA (1 μCi, 3.6 Ci/mmol, 280 pmol, 5.67 μM), with the indicated amounts of enzyme and eIF5A substrate protein. The reaction mixture was incubated at 30
• C for 1 h or for the indicated times. The reaction was stopped by addition of 10 % trichloroacetic acid. Carrier BSA (500 μg) was then added and the samples kept on ice for 30 min. The trichloroacetic acid-precipitated proteins were centrifuged in a microfuge (15000 g) at 4
• C for 5 min and the precipitates were washed three times with 10 % trichloroacetic acid to remove free 
Chemical synthesis of acetylhypusine
Acetylhypusine [(4-acetamido-2-hydroxybutyl)lysine] was prepared from hypusine using a selective acetylating reagent.
To 316 mg (1.36 mmol) (2S,9R)-hypusine(free-base)(2) in 5 ml of ethanol at 5
• C was added 365 mg (1.49 mmol, 1.1 eq) of 2-trifluoroethyl-N,N-diacetylaniline [39] in one portion with stirring. After continued stirring for 2 h at room temperature, the solvent was evaporated and the residue was chromatographed on silica gel with a mixture of methylene chloride/methanol/concentrated ammonium hydroxide (2:2:1, by vol.). The residue, after removal of solvent, was dissolved in 1 ml of water and the pH was adjusted to 5.2 with dilute HCl. Removal of solvent and addition of ethanol afforded a crystalline product as the mono HCl salt which was recrystallized from water/ethanol. Yield 212 mg (45 % Structural verification of this product as 11-acetamido-2-amino-7aza-9-hydroxyundecanoic acid was attained through identification of lysine as the sole dinitrophenylated amino acid produced upon dinitrophenylation of its oxidation products, under conditions described previously [40] . CH 3 The two 16-mer peptides were prepared by a solid-phase procedure as previously described for the 9-mer eIF5A peptides [41] and their purity and identity were validated by TLC and by amino acid analysis after acid hydrolysis.
Identification of acetyl-lysine, acetylhypusine, and acetyldeoxyhypusine, hypusine and deoxyhypusine by ion-exchange chromatographic separation
For identification of radiolabelled amino acid component of the HAT, SSAT1 and SSAT2 reaction products, trichloroacetic acidprecipitated proteins were exhaustively digested with pronase as follows: trichloroacetic acid-precipitated proteins (washed free of [ 3 H]AcCoA with repeated trichloroacetic acid washes) were washed with acetone to remove trichloroacetic acid, and the protein pellet was resuspended in 0.1 ml of 0.1 M Tris/HCl, pH 8.0. To this, 10 μl of pronase (50 mg/ml in the same buffer) and thimerosal (0.1 mg/ml) were added and the mixture was incubated for 24 h at 37
• C. The pronase addition was repeated three times and after 72 h of digestion, 30 μl of 50% trichloroacetic acid was added. After removal of trichloroacetic acid precipitates, the radioactive component in the trichloroacetic acid supernatant was analysed by ion-exchange chromatography on a Dionex D-400 analyser using a DC-6A resin column (0.4×8 cm) (Dionex) as described previously [42] and a buffer system of: 10 min, 66 mM sodium citrate, pH 4.31; 10 min, 13.2 mM sodium citrate buffer, pH 5.55, containing 1.5 M NaCl; and 20 min, 66 mM sodium citrate, pH 4.31. Fractions were collected every 1 min for radioactivity counting or the amino acids were detected by post-column fluorometric detection after reaction with orthophthaldehyde.
Purification of eIF5A from bovine testis
We purified bovine testis eIF5A (hypusine form) using the radiolabelled eIF5A([ 3 H]Dhp) as a tracer, since the deoxyhypusine form and the hypusine form have virtually the same pI values and ion-exchange chromatographic properties. Bovine testis (1 kg from PelFreez) was chopped and ground in a blender in 1.0 litre of ice-cold Buffer A (Tris-acetate, pH 6.7, 0.1 mM EDTA, 1 mM DTT, 1 mM benzamidine and 1 mM PMSF). The lysate was centrifuged at 15000 g for 40 min. The supernatant was passed through glass wool to remove debris. A radioactive tracer protein, eIF5A([ 3 H]Dhp) (10 6 d.p.m., 62 pmol, 1 μg) was added to the clarified lysates and the mixture was applied to a 120 ml size column of DEAE-Sepharose. Throughout the purification steps, the fractions containing eIF5A were identified by SDS/PAGE and by counting the radioactivity. After washing the column with 200 ml of Buffer A, the proteins were eluted with a salt gradient (100 ml each step) of 0.1, 0.2, 0.3, 0.4 and 0.5 M KCl in Buffer A, and 25 ml fractions were collected. A 100 μl aliquot of each fraction was counted and the radioactive fractions were pooled. This pool was treated with 40−80 % ammonium sulfate. The proteins from ammonium sulfate precipitation (∼ 2 g) after dialysis in Buffer A were applied to a Q-Sepharose column (70 ml size). After washing the column with 200 ml of buffer A, the proteins were eluted with a stepwise gradient (50 ml each step) of 0.1, 0.15, 0.2, 0.25, 0.3, 0.35, 0.4 and 0.5 M KCl in Buffer A and 25 ml fractions were collected. The radioactivity in each fraction was counted and the two fractions with the highest radioactivity were pooled and dialysed against Buffer B (50 mM Tris-acetate, pH 7.0, 1 mM DTT and 0.1 mM EDTA) and applied to a SP-Sepharose column (20 ml). The sample was applied, and the column was washed with 100 ml of Buffer B. The bound proteins were eluted with a KCl gradient of 0.1 M (25 ml), 0.2 M (25 ml), 0.3 M (50 ml), 0.4 M (50 ml) and 0.5 M (50 ml). Fractions of 5 ml were collected. The two fractions with the highest radioactivity were pooled and ammonium sulfate added to a 1.5 M final concentration for phenyl-Sepharose chromatography (10 ml size). The column was equilibrated in Buffer B containing 1.5 M ammonium sulfate. The pooled proteins were applied and the column was washed with 20 ml of the initial buffer (1.5 M ammonium sulfate). The bound proteins were eluted with decreasing concentration of ammonium sulfate; steps (10 ml each) of 1.35, 1.2, 1.05, 0.9, 0.75, 0.6, 0.45, 0.3 and 0.15 M, and 5 ml fractions were collected. The three fractions containing eIF5A protein and the radioactivity were pooled and concentrated and equilibrated in 50 mM Tris/HCl, pH 7.5, 0.1 M KCl and 1 mM DTT. • C for 2 h. A small aliquot (10 μl) of the reaction mixture was mixed with [ 3 H]AcCoA (8 μl) and 2 μl of 5× Buffer H to monitor the progress of acetylation at 0, 2 and 4 h. At 2 and 4 h, extra unlabelled AcCoA (100 nmol) and enzyme (40 μg) were added and the majority of eIF5A was acetylated at 6 h. As a control for non-acetylated eIF5A, 0.1 mg of eIF5A was incubated in a parallel reaction mixture (30 μl, but without SSAT1) for the same period at 30
• C. The SSAT1 reaction mixture was applied to a column of SP-Sepharose (8 ml size) equilibrated with Tris buffer C (50 mM Tris/HCl, pH 7.4, and 1 mM DTT) and the column was washed with 10 ml of buffer C. The acetylated and non-acetylated eIF5A proteins were separated upon elution with a KCl gradient (5 ml each step) of 0.1, 0. • C for 20 min. To each tube, 0.4 ml of 0.2 M Na 2 HPO 4 buffer, pH 8.0, was added. Then 1 ml of ethyl acetate was added and the tubes shaken for 10 min. The tubes were centrifuged in a microfuge for 10 min. The upper layer (∼ 0.9 ml) was carefully removed and the radioactivity was counted.
RESULTS
Acetylation of eIF5A by histone acetyltransferases and spermidine/ spermine acetyltransferase
Several lines of evidence indicating the acetylation of eIF5A at specific lysine residues Lys 47 [4] and Lys 68 [43] have been reported. In an effort to identify the cellular acetyltransferase that may be responsible for the acetylation of eIF5A, we tested four HAT enzymes, p300, CBP, PCAF, hGCN5 as well as SSAT1 and a related enzyme SSAT2 using recombinant eIF5A proteins produced in E. coli, eIF5A(Lys) and eIF5A(Hpu) in vitro ( Figures 1A and 1B) . All four of the HAT enzymes were effective in the acetylation of histone III as a substrate (results not shown). However, a highly selective pattern of acetylation was observed with recombinant eIF5A(Lys) or eIF5A(Hpu) as substrate. The eIF5A(Lys) was effectively acetylated by p300 and moderately by CBP, as judged by incorporation of radioactivity from [ 3 H]AcCoA into protein and also by Western blotting with an anti-AcLys antibody ( Figure 1A) .
A totally distinct acetylation pattern was observed for recombinant eIF5A(Hpu) ( Figure 1B) . Only very faint labelling and that from a p300-catalysed reaction with eIF5A(Lys) (the same or similar reaction as shown in Figure 1 ) were exhaustively digested with pronase and the radioactive amino acids in the digests were separated by ion-exchange chromatography. (B) Acetylhypusine was identified by its elution time, which was identical to that of the chemically synthesized acetylhypusine standard determined by fluorometric detection. The position of each amino acid is indicated and the chemical structure of acetylhypusine is shown. AcDhp, acetyldeoxyhypusine; AcHpu, acetylhypusine; Dhp, deoxyhypusine; Hpu, hypusine. of eIF5A(Hpu) was observed with p300, but strong labelling was observed with SSAT1. No other enzyme resulted in eIF5A(Hpu) acetylation. Curiously, eIF5A(Hpu) acetylated by SSAT1 was not detected by the anti-AcLys antibody, suggesting that acetylation did not occur at any of its lysine residues. This observation, together with the fact that only the hypusine-containing protein, but not the precursor, was acetylated by SSAT1, indicates that acetylation occurs at the hypusine residue. We also tested natural mammalian eIF5A as substrates for SSAT1. In mammalian cells and tissues, natural eIF5A exists predominantly as the fully modified hypusine-containing form [25, 27] . Mammalian eIF5A proteins (hypusine form) purified from three different sources, CHO (Chinese hamster ovary) cells, hRBCs (human red blood cells) or from rabbit reticulocytes, all acted as effective substrates for SSAT1 ( Figure 1C) as the recombinant eIF5A(Hpu) produced in E. coli ( Figure 1B) . Deoxyhypusine-containing eIF5A, eIF5A(Dhp), was also acetylated by SSAT1, although it was not as good a substrate as the hypusine-containing protein. Interestingly, unlike the acetylated eIF5A(Hpu), the acetylated eIF5A(Dhp) was recognized by the anti-AcLys antibody ( Figure 1C) , probably due to the acetylated butyl amino side chain present in both eIF5A(Lys) and eIF5A(Dhp).
Acetylation of eIF5A(Hpu) or eIF5A(Dhp) by SSAT1 occurs selectively at the hypusine/deoxyhypusine residue
In order to confirm the sites of acetylation, acetylated eIF5A proteins, as shown in Figure 1 , were exhaustively digested using pronase and the digests were separated by ion-exchange chromatography (Figure 2, upper panel) . The eIF5A(Lys) acetylated by p300 contained only AcLys as the labelled component, consistent with the Western blot results with the anti-AcLys antibody. In contrast, the major radioactive component in the eIF5A(Hpu) acetylated by SSAT1 was identified as acetylhypusine with the acetyl moiety on the N-terminal group of the hypusine side chain (see structure in Figure 2 ). The radioactivity eluted at the exact position of a synthetic acetylhypusine standard, whose chemical structure was validated by NMR (bottom panel, Figure 2 ). Furthermore, it was destroyed by acid hydrolysis, as the acetyl moiety was cleaved from acetylhypusine, as expected. Only a small amount of acetyl lysine (<3 % of the total) was found in the digest of acetylated eIF5A(Hpu) and it is not clear whether this was derived from eIF5A or from SSAT1 enzyme autoacetylation. When radiolabelled eIF5A(Dhp), with radioactivity in the terminal aminobutyl side chain of deoxyhypusine, was used as a substrate for the SSAT1 reaction with [ 3 H]AcCoA, two radioactive components were detected after exhaustive proteolytic digestion, deoxyhypusine and an early peak at the expected position of acetyldeoxyhypusine. This radiolabelled component of acetylated eIF5A(Dhp) elutes at a time 4−5 min later than that for acetylhypusine, as expected, just as deoxyhypusine elutes 4−5 min later than hypusine. This may be because the absence of the hydroxy group in deoxyhypusine, or its acetylated form, permits stronger hydrophobic interaction with the resin. The radiolabelled material in the early peak (acetyldeoxyhypusine) was completely converted to deoxyhypusine after acid hydrolysis, confirming its identity as acetyldeoxyhypusine.
Specificity of the SSAT1 reaction: inhibition of eIF5A acetylation by polyamines, hypusine, deoxyhypusine, eIF5A(Lys) and eIF5A-derived peptides
The acetylation reaction by SSAT1 increased with time and was dependent on the substrate concentration (Figure 3 ). The K m for eIF5A(Hpu) was estimated to be approx. 60 μM (results not shown). Thus eIF5A(Hpu) is a fairly good substrate for SSAT1. The long side chain of the hypusine or deoxyhypusine residue resembles the polyamine spermidine and this may be the molecular basis of its acetylation by SSAT1. In order to test this hypothesis and to compare its substrate efficiency with those of polyamines, we tested polyamines, the analogue BENSpm, free hypusine and deoxyhypusine, eIF5A(Lys) and eIF5A peptides (16 mer) as inhibitors (Figure 4 ). SSAT1 has been reported to be specific for the aminopropyl moiety; it does not effectively acetylate the aminobutyl moiety of the polyamines, putrescine, . After 1 h at 30 • C, the reaction was stopped by addition of 10 % trichloroacetic acid and the radioactivity incorporated into protein was measured. Representative data is shown from two independent experiments whose results were similar. Dhp, deoxyhypusine; hSpd, sym-homospermidine; Hpu, hypusine; Ptc, putrescine; Spd, spermidine; Spm, spermine.
spermidine and sym-homospermidine [44] . Consistent with this finding, putrescine and sym-homospermidine were poor inhibitors of eIF5A(Hpu) acetylation causing little or no inhibition at 5 μM. In contrast, spermidine and spermine (at 5 and 50 μM) strongly inhibited eIF5A(Hpu) acetylation (substrate at 3 μM), indicating that they are better substrates for the SSAT1 than eIF5A(Hpu) (Figure 4 ). BENSpm exhibited a moderate inhibition.
Hypusine or deoxyhypusine, as the free amino acid, did not inhibit acetylation of eIF5A(Hpu) (no or little inhibition at 5−50 μM, 10−20 % inhibition at 250 μM). This finding indicates that eIF5A(Hpu) acetylation by SSAT1 is not merely by virtue of the similarity of the long side chain of these amino acids to the polyamines and that unlike the protein eIF5A(Hpu), these free amino acids are not good substrates for SSAT1. Then we tested two synthetic peptides (16 mers) modelled on the sequence of amino acids surrounding the hypusine residue 50, (IVEMSTSKTGK 50 HGHAK and IVEMSTSKTGDhp 50 HGHAK) one with Lys 50 and the other with deoxyhypusine 50 . The lysine residue peptide did not inhibit eIF5A acetylation by SSAT1 (even at 0.5 mM), whereas the deoxyhypusine-containing counterpart caused moderate inhibition (50 % and 80 % at 50 and 500 μM, respectively). Thus the deoxyhypusine or hypusine residue of eIF5A seems to be critical for its binding to SSAT1, even though they are not substrates as free amino acids. The intact eIF5A(Lys) protein was better than the 16 mer lysine peptide, but not as inhibitory as the deoxyhypusine peptide. These findings suggest that both the extended amino acid sequences (macromolecular structure) of eIF5A and the target residues (hypusine and deoxyhypusine) are important for the binding and modification of eIF5A(Hpu) and eIF5A(Dhp) by SSAT1.
Molecular interaction between eIF5A and SSAT1
The observation that eIF5A(Hpu) and eIF5A(Dhp) are good substrates for SSAT1, whereas free hypusine, deoxyhypusine and short peptide derivatives are not, suggests that SSAT1 recognizes the eIF5A macromolecule as a substrate, not just the hypusine or deoxyhypusine residue. Therefore we examined the interaction of eIF5A and SSAT1 by pull-down assays after cotransfection of GFP (green fluorescent protein)−eIF5A and FLAG−SSAT1 in HeLa cells ( Figure 5 ). As was reported previously [45] , GFP−eIF5A was co-transfected with the hypusine modification enzymes DHS and DOHH to produce the hypusine-modified form. The expression level of FLAG-SSAT1 was very low in cells transfected with either the SSAT1 vector alone ( Figure 5A , top panel, lane 2) or in those co-transfected (A) The bovine testis eIF5A (hypusine form) was mixed with the radioactive tracer eIF5A([ 3 H]Dhp) and was incubated with SSAT1 as described in the Experimental section. The acetylated eIF5A (fractions 13−15) was separated by ion-exchange chromatography on SP-Sepharose resin. Bovine testis eIF5A was completely acetylated, whereas the radioactive tracer, eIF5A([ 3 H]Dhp) was not, probably because the hypusine-containing eIF5A is a better substrate for SSAT1 than the deoxyhypusine-containing form. The purity of non-acetylated and acetylated eIF5A is shown in the inset. (B) The methionyl-puromycin synthesis assay was conducted using acetylated eIF5A prepared in (A) and a non-acetylated counterpart (from a parallel acetylation reaction mixture but without SSAT1), as described in the Experimental section, in duplicate with 0.1, 0.3 and 1.0 μg of bovine testis eIF5A and its acetylated counterpart. Average values are of duplicates. BT, bovine testis; BT-Ac-eIF5A, acetylated bovine testis eIF5A.
with the vectors encoding eIF5A, DHS and DOHH ( Figure 5A , top panel, lane 3). Expression of GFP−eIF5A was remarkably low in cells co-transfected with SSAT1 ( Figure 5A , bottom panel, lane 3) due to a novel activity of SSAT1 in suppression of exogenous gene expression [46] . Since SSAT1 has a very short half-life and is stabilized by the polyamine analogue BENSpm [1] , we treated cells with this compound after transfection. Indeed, the expression level of SSAT1 was restored in the presence of BENSpm ( Figure 5A , top panel, lanes 5 and 6) and so was the expression of GFP−eIF5A ( Figure 5A , bottom panel, lane 6). Upon immunoprecipitation of the cell lysate with the anti-FLAG antibody, GFP−eIF5A (hypusine form) was pulled down with FLAG−SSAT1 ( Figure 5B, lane 6) . Reciprocally, FLAG−SSAT1 was immunoprecipitated along with eIF5A when the lysate was immunoprecipitated with anti-eIF5A antibody ( Figure 5B ). Taken together, these results suggest a specific physical interaction between eIF5A and SSAT1.
Effects of hypusine acetylation on eIF5A activity in vitro
Considering the stringent requirement for the hypusine for eIF5A activity, acetylation of the N-terminal group of the hypusine side chain is expected to affect molecular interactions involving the hypusine residue and therefore the biological activity of eIF5A. We have prepared acetylated eIF5A, by an in vitro SSAT1 reaction with eIF5A (hypusine form) isolated from bovine testis. The acetylated eIF5A protein, with a more acidic pI, was separated from its non-acetylated counterpart upon ion-exchange chromatography on SP-Sepharose column ( Figure 6A ). The activity of the acetylated eIF5A was compared with that of nonacetylated bovine eIF5A incubated in a parallel reaction mixture without SSAT1, using the methionyl-puromycin synthesis assay ( Figure 6B ). The activity of acetylated eIF5A ( Figure 6B ) was lost, indicating that acetylation of the hypusine side chain inactivates eIF5A. The activity of recombinant eIF5A(Hpu) produced in E. coli was also lost upon hypusine acetylation by SSAT1 (results not shown).
DISCUSSION
In the present paper we describe definitive biochemical evidence for acetylation of eIF5A at its hypusine residue by SSAT1. eIF5A is the first reported target substrate protein of SSAT1 to be completely inactivated by acetylation. SSAT1 selectively targets the N-terminal group of the deoxyhypusine/hypusine side chain of eIF5A, which is located at the tip of an exposed hypusine loop in the N-terminal domain. The specificity may be due, in large part, to the similarity of the hypusine side chain to the polyamine spermidine. However, the acetylation of eIF5A by SSAT1 probably involves a specific macromolecular interaction between the enzyme and substrate, since free hypusine or deoxyhypusine does not appear to act as a substrate for SSAT1. Even the 16-mer deoxyhypusine peptide exerted only modest inhibition of eIF5A hypusine acetylation. Acetylation of the hypusine/deoxyhypusine residue abolished the activity of eIF5A in methionyl-puromycin synthesis in vitro. The acetylation reduces the strong basic charge of the hypusine loop and may disturb the binding of eIF5A to the ribosome and to other acidic binding partners.
The hypusine modification is essential for eIF5A activity and thereby defines a key function of polyamines in cell proliferation [47] . In cells depleted of natural polyamines by inhibitors of their biosynthetic enzymes or by induction of their catabolic enzyme, SSAT1, only spermidine or those closely related analogues that serve as a substrate for deoxyhypusine/hypusine modification can support growth of mammalian cells in the long term [7, 20] . Polyamine biosynthetic enzymes, such as ornithine decarboxylase and adenosylmethionine decarboxylase, as well as the polyamine catabolic enzyme SSAT1, have been targeted for anti-tumour therapy and chemoprevention [48] . Furthermore, the hypusine biosynthetic enzymes, deoxyhypusine synthase and deoxyhypusine hydroxylase, have been also explored as targets for intervention in aberrant cell proliferation. A drawback in targeting the hypusine modification is that it is not possible to deplete eIF5A rapidly, since eIF5A is abundant and has a long half-life.
Furthermore, there is no pathway known to convert hypusinecontaining eIF5A back to an inactive precursor and the activity of cellular eIF5A cannot be regulated by reversing the hypusine modification.
In this regard, reversible modification of eIF5A, such as acetylation or phosphorylation, may be invoked for rapid regulation of eIF5A activity without a change in its protein level. Although phosphorylation of yeast eIF5A at a serine residue (the second residue from the N-terminus) was detected, it probably is not required for eIF5A activity or its regulation, since the phosphorylated eIF5A is fully active [49] and a serine to alanine residue substitution mutant supports yeast growth [50] . Acetylation of eIF5A at two specific lysine residues, Lys 47 [33] and Lys 68 [43] has been reported. K68D and K68A mutant forms support yeast growth (results not shown), suggesting that acetylation at this site does not affect eIF5A activity. In contrast, the loss of activity of the K47D mutant supports the notion that eIF5A activity is negatively regulated by acetylation at Lys 47 [4] . Indeed, our previous data demonstrated that eIF5A(Lys) is the major acetylated protein in cells detected by an anti-AcLys antibody [45] . Furthermore, eIF5A was identified as the main target substrate of the NAD-dependent deacetylase SIRT2 in S. cerevisiae [51] . Thus eIF5A may be potentially regulated by two different acetylation mechanisms, one at Lys 47 by a cellular HAT enzyme and the other at the hypusine/deoxyhypusine residue by SSAT1, depending on special physiological conditions. SSAT2 (TLAT) was initially considered to be a candidate enzyme to acetylate eIF5A, because it is quite inefficient toward polyamines but can efficiently acetylate thialysine, 5-hydroxy-L-lysine, S-(aminoethyl)-homocysteine, and O-(aminoethyl)-Lserine, and has a modest activity on lysine residues itself. However, no acetylation of eIF5A(Hpu) or eIF5A(Lys) was observed with SSAT2. SSAT1 has been reported to exert specificity toward the aminopropyl moiety of spermidine, spermine or other low-molecular-mass amine substrates. The aminobutyl moiety in putrescine or sym-homospermidine was a poor substrate for the rat liver enzyme [44] . The weak inhibition of eIF5A(Hpu) acetylation by putrescine and sym-homospermidine, compared with the strong inhibition by spermidine and spermine, is consistent with the aminopropyl specificity. Interestingly, such structural specificity does not seem to apply to protein substrates, considering the acetylation of its own Lys 26 , and of the eIF5A deoxyhypusine or hypusine residue. SSAT1 was also reported to metabolize a drug, amantadine hydrochloride, used in the profilaxis and treatment of influenza A virus infection, by acetylating an achiral polycyclic aliphatic primary amine [52] .
SSAT1 may have cellular functions in addition to polyamine metabolism. SSAT1 has been proposed to be involved in the integrin-mediated cell migration via its binding to the α9β1 integrin, which functions in conjunction with the potassium channel K ir 4.2 modulated by local polyamine concentrations [11] . Both SSAT1 and SSAT2 (TLAT) were implicated in the regulation of HIF-1α, supposedly by promoting its ubiquitination and degradation by the 26S proteosome. Although SSAT1 was reported to interact with these proteins, HIF-1α, integrin β9, SLC3A2 and the SSAT1 activity appeared to be critical for HIF-1α degradation [13] or integrin β9-mediated cell migration [11] , there is no evidence for acetylation of these binding proteins by SSAT1. Furthermore, co-transfection with SSAT1 suppresses exogenous expression of other reporter proteins [46] . Although this effect was also dependent on SSAT1 enzyme activity, the loss of exogenous gene expression could not be simply attributed to a decrease in the overall cellular polyamine pools [46] . Thus it is unclear whether it was mediated by polyamine acetylation (and consequent depletion of local polyamines) and/or by acetylation of other unknown protein substrates. The autoacetylation of its own Lys 26 residue and the hypusine/deoxyhypusine residue of eIF5A by SSAT1 and the spacious active site of the SSAT1 crystal structure leave open the possibility of other SSAT1 target substrate proteins [14] .
Whereas hypusine modification is tied to spermidine and its biosynthesis, it is intriguing to note that a potential eIF5A inactivation mechanism is linked to the polyamine catabolic enzyme SSAT1. SSAT1 induction leads to growth inhibition by depletion of cellular polyamines, which in turn leads to a decrease in hypusine-containing eIF5A. Under normal cellular conditions, the SSAT1-mediated hypusine acetylation is probably not significant, considering that the SSAT1 enzyme level is low and that the eIF5A concentration is much lower than those of free cellular polyamines. However, upon super-induction of SSAT1 in cells, hypusine acetylation by SSAT1 may lead to inactivation of eIF5A (further reducing the level of biologically active eIF5A), whereas new synthesis of hypusine is blocked due to depletion of spermidine. Whether such regulation of the eIF5A level and activity contributes to growth inhibition in the case of SSAT1 super-induction and polyamine depletion warrants further investigation.
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